Paid Clinical Trials Scottsdale

Discover 780 paid clinical trials in Scottsdale, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 780

Observational StudyPancreatic Cancer Early Detection Consortium

Recruiting

Sponsor:

Arbor Research Collaborative for Health

Location:

Scottsdale AZ, Phoenix AZ, Saint George UT, La Jolla CAshow 39 more

Code:

NCT04970056

Conditions

Pancreas Cancer

Pancreas Cyst

Pancreatic Ductal Adenocarcinoma

Genetic Predisposition

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use DisorderA Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder

Recruiting

PHASE2

Sponsor:

Eli Lilly and Company

Location:

Scottsdale AZ, Las Vegas NV, Lemon Grove CA, San Diego CAshow 21 more

Code:

NCT06817356

Conditions

Alcohol Use Disorder

Eligibility Criteria

Sex: All

Age: 21 - 65

Healthy Volunteers: Not accepted

Interventions

Mazdutide

Placebo

SAR444656Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis

Recruiting

PHASE2

Sponsor:

Sanofi

Location:

Scottsdale AZ, Dearborn MI, Troy MI, Pittsburgh PAshow 4 more

Code:

NCT06058156

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SAR444656 (KT-474)

Placebo

PF-07220060 with LetrozoleStudy of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

Recruiting

PHASE3

Sponsor:

Pfizer

Location:

Scottsdale AZ, Mesa AZ, Phoenix AZ, Gilbert AZshow 23 more

Code:

NCT06760637

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-07220060

letrozole

abemaciclib

palbociclib

ribociclib

IDE196 & CrizotinibIDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma

Recruiting

PHASE2

PHASE3

Sponsor:

IDEAYA Biosciences

Location:

Scottsdale AZ, La Jolla CA, Los Angeles CA, Denver COshow 25 more

Code:

NCT05987332

Conditions

Metastatic Uveal Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

IDE196

Crizotinib

Pembrolizumab

Ipilimumab

Nivolumab

Observational StudyData Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality.

Recruiting

Sponsor:

Fairtility

Location:

Scottsdale AZ

Code:

NCT06928337

Conditions

Fertility Disorders

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Accepted

Interventions

AI evaluation of oocytes.

GI-102, Pembrolizumab, T-DXdA Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Recruiting

PHASE1

PHASE2

Sponsor:

GI Innovation, Inc.

Location:

Scottsdale AZ, Rochester MN, Cleveland OH, Jacksonville FLshow 1 more

Code:

NCT05824975

Conditions

Advanced Solid Tumor

Metastatic Solid Tumor

Soft Tissue Sarcoma (STS)

Platinum-resistant Ovarian Cancer (PROC)

Hepatocellular Carcinoma (HCC)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

GI-102 subcutaneous (SC)

GI-102

doxorubicin

paclitaxel

bevacizumab

JAB-21822JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation

Recruiting

PHASE1

PHASE2

Sponsor:

Jacobio Pharmaceuticals Co., Ltd.

Location:

Scottsdale AZ, Phoenix AZ, Salt Lake City UT, Jacksonville FL

Code:

NCT05002270

Conditions

Advanced Solid Tumor

NSCLC

CRC

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

JAB-21822 (KRAS G12C inhibitor)

Cetuximab (EGFR inhibitor)

Reduced Dose RadiotherapyReduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma

Recruiting

PHASE2

Sponsor:

Mayo Clinic

Location:

Scottsdale AZ, Mankato MN, Albert Lea MN, Rochester MNshow 3 more

Code:

NCT06386315

Conditions

Indolent B-Cell Non-Hodgkin Lymphoma

Recurrent Indolent B-Cell Non-Hodgkin Lymphoma

Refractory Indolent B-Cell Non-Hodgkin Lymphoma

Recurrent Indolent Non-Hodgkin Lymphoma

Refractory Indolent Non-Hodgkin Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Computed Tomography

Endoscopic Procedure

Involved-site Radiation Therapy (3 Fractions)

Involved-site Radiation Therapy (12 Fractions)

Positron Emission Tomography

Observational StudyADVENT Post Approval Study

Recruiting

Sponsor:

Boston Scientific Corporation

Location:

Scottsdale AZ, Oakland CA, Tulsa OK, Houston TXshow 25 more

Code:

NCT06431815

Conditions

Paroxysmal Atrial Fibrillation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

FARAPULSE™ Pulsed Field Ablation System